Immunological parameters in patients with epilepsy

S Bostantjopoulou1, O Hatzizisi, O Argyropoulou

  • 13rd Department of Neurology, University of Thessaloniki, Greece.

Functional Neurology
|January 1, 1994
PubMed

Insights

Epilepsy patients exhibit immune system defects, including altered T-lymphocyte counts and immunoglobulin levels. Antiepileptic drugs like carbamazepine and valproate may modify these immune responses.

Area of Science:

  • Immunology
  • Neurology

Background:

  • Epilepsy is associated with complex pathophysiological mechanisms.
  • Immune system dysregulation may play a role in epilepsy.
  • The impact of antiepileptic drugs on immune parameters is not fully understood.

Purpose of the Study:

  • To investigate immunological differences between epilepsy patients and healthy controls.
  • To assess the influence of carbamazepine and valproate on immune markers in epilepsy.

Main Methods:

  • Serum levels of IgA, IgG, IgM, C3, and C4 were measured.
  • T and B lymphocyte counts, including T-lymphocyte subsets (CD4, CD8), were analyzed.
  • Immunological parameters were compared among epilepsy patients (medicated and unmedicated) and controls.

Main Results:

  • Epilepsy patients showed reduced CD4+ T-cells, increased CD8+ T-cells, a lower CD4/CD8 ratio, elevated IgG and IgM levels, and decreased C4 complement component.
  • Unmedicated patients exhibited all these immune abnormalities.
  • Carbamazepine and valproate treatments were associated with specific alterations in CD4/CD8 ratio, IgG, IgM, and C4 levels.

Conclusions:

  • Epilepsy is linked to a defective immune mechanism.
  • Antiepileptic drug treatment can modify these immune alterations.
  • Further research is needed to elucidate the clinical significance of these immune changes in epilepsy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.